Second Talcum Linked Mesothelioma Trial Begins

Second Talcum Linked Mesothelioma Trial Begins

Introduction

In addition to the ovarian cancer lawsuits, Johnson & Johnson is now facing Mesothelioma lawsuits along with Imerys Talc America and Cyprus Amax Minerals Co., allegations include that the asbestos from the talc products is the cause of mesothelioma (a tumor of the tissue that lines the lungs, stomach, heart and other organs) development. This is the second related trial which began on January 22, 2018, in Middlesex County, New Jersey Superior Court. The plaintiff, in this case, alleges that he developed mesothelioma on exposure to the asbestos present in the talc manufactured by the named defendants. The trial was put on hold for evidentiary dispute by the Superior Court Judge Ana Viscomi, overseeing the trial. Allegations include failure to warn in spite of being aware of the increased risk of mesothelioma on exposure to asbestos. However, the defendants argue that the products never contained asbestos, and maintain that the plaintiffs used faulty test methods. This trial is expected to run for two months.

The first mesothelioma- talc trial ended in a defense verdict in November 2017 in Los Angeles Superior Court.